Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Neuroone Medical Technologies (NMTC) Short-term Investments (2022 - 2023)

Neuroone Medical Technologies filings provide 2 years of Short-term Investments readings, the most recent being $995432.0 for Q1 2023.

On a quarterly basis, Short-term Investments changed N/A to $995432.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $995432.0, a N/A change, with the full-year FY2022 number at $3.0 million, changed N/A from a year prior.
Short-term Investments hit $995432.0 in Q1 2023 for Neuroone Medical Technologies, down from $3.0 million in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $3.0 million in Q3 2022 to a low of $995432.0 in Q1 2023.